Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
665 ARTÍCULOS , VIENDO DEL 16 AL 30
Monsalvo-Maraver LÁ, Maya-López M, Rangel-López E, Túnez I, Tinkov AA, Skalny A, Ferrer B, Aschner M, Santamaría A.
CNS Neurol Disord Drug Targets. 2023;22(7):1039-1056. doi: 10.2174/1871527321666220616094036.
DYRK1A Inhibitors and Perspectives for the Treatment of Alzheimer's Disease
de Souza MM, Cenci AR, Teixeira KF, Machado V, Mendes Schuler MCG, Gonçalves AE, Paula Dalmagro A, André Cazarin C, Gomes Ferreira LL, de Oliveira AS, Andricopulo AD.
Curr Med Chem. 2023;30(6):669-688. doi: 10.2174/0929867329666220620162018.
Das S, Ramachandran AK, Halder D, Akbar S, Ahmed B, Joseph A.
CNS Neurol Disord Drug Targets. 2023;22(7):973-993. doi: 10.2174/1871527321666220629162229.
Anticholinesterase Agents For Alzheimer's Disease Treatment: An Updated Overview
Llanes LC, Kuehlewein I, França IV, da Silva LV, da Cruz Junior JW.
Curr Med Chem. 2023;30(6):701-724. doi: 10.2174/0929867329666220803113411.
Genetic Causes of Alzheimer's Disease and the Neuroprotective Role of Melatonin in its Management
Sundram S, Malviya R, Awasthi R.
CNS Neurol Disord Drug Targets. 2023;22(9):1302-1312. doi: 10.2174/1871527321666220901125730.
Current Naturopathy to Combat Alzheimer's Disease
Chakrovorty A, Bhattacharjee B, Saxena A, Samadder A, Nandi S.
Curr Neuropharmacol. 2023;21(4):808-841. doi: 10.2174/1570159X20666220927121022.
Shah U, Shah A, Patel S, Patel A, Patel M, Solanki N, Patel S, Patel A, Patel V, Patel B.
CNS Neurol Disord Drug Targets. 2023;22(10):1462-1471. doi: 10.2174/1871527322666221005124808.
Recent Advances in the Development of Nitrogen-containing Heterocyclic Anti-alzheimer's Agents
Kumar A, Nehra B, Singh D, Kumar D, Chawla PA.
Curr Top Med Chem. 2023;23(13):1277-1306. doi: 10.2174/1568026623666221019152502.
A Pilot Study of Near-Infrared Light Treatment for Alzheimer's Disease
Chen L, Xue J, Zhao Q, Liang X, Zheng L, Fan Z, Souare ISJ, Suo Y, Wei X, Ding D, Mao Y.
J Alzheimers Dis. 2023;91(1):191-201. doi: 10.3233/JAD-220866.
Recent Nanoscale Carriers for Therapy of Alzheimer's Disease: Current Strategies and Perspectives
Zakharova L, Gaynanova G, Vasilieva E, Vasileva L, Pavlov R, Kashapov R, Petrov K, Sinyashin O.
Curr Med Chem. 2023;30(33):3743-3774. doi: 10.2174/0929867330666221115103513.
Natural Products with BACE1 and GSK3β Inhibitory Activity
Prado PC, Lima JA, Hamerski L, Rennó MN.
Mini Rev Med Chem. 2023;23(7):881-895. doi: 10.2174/1389557523666221118113923.
Necroptosis and Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Opportunities
Zhang R, Song Y, Su X.
J Alzheimers Dis. 2023;94(s1):S367-S386. doi: 10.3233/JAD-220809.
Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer's Disease
Yamali C, Donmez S.
Mini Rev Med Chem. 2023;23(7):869-880. doi: 10.2174/1389557523666221201145141.
NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer's Disease
Painuli S, Semwal P, Zam W, Taheri Y, Ezzat SM, Zuo P, Li L, Kumar D, Sharifi-Rad J, Cruz-Martins N.
Comb Chem High Throughput Screen. 2023;26(12):2099-2112. doi: 10.2174/1386207325666220428112541.
Role of Polyphenols in Alleviating Alzheimer's Disease: A Review
William Raja TR, Duraipandiyan V, Ignacimuthu S, Janakiraman U, Packiam SM.
Curr Med Chem. 2023;30(35):4032-4047. doi: 10.2174/0929867330666221202152540.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.